Vertically Integrated Company Developing Science-Driven Cannabinoid Biopharmaceuticals

Developing science-driven synthetic cannabinoid therapies while driving innovation in the endocannabinoid space

Ir
Message: Applied BioSciences Corp. Provides Corporate Update and Discusses Strategy for Focus on Building High-Value BioPharma Pipeline with the Stock Day Podc

Applied BioSciences Corp. Provides Corporate Update and Discusses Strategy for Focus on Building High-Value BioPharma Pipeline with the Stock Day Podc

posted on Nov 19, 2019 08:35AM

Phoenix, Arizona--(Newsfile Corp. - November 19, 2019) - The Stock Day Podcast Host Everett Jolly welcomed Dr. Ray Urbanski, CEO of Applied BioSciences Corp. (OTCQB: APPB) ("the Company"), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas.

Dr. Urbanski provided a corporate overview and updated listeners on the current projects within the Applied BioPharma division. "We have exclusively licensed, patented, synthetically-derived molecular candidates that target the endocannabinoid system," said Urbanski. He further explained that the Company is focusing on advancing its programs for treatments for diseases like Type II Diabetes, obesity and inflammatory diseases.

"We believe that Applied BioPharmaceuticals' core competency in identifying unique therapeutic opportunities and moving them through human clinical trials is where we're really going to add value," said Urbanski.

To hear Raymond Urbanski's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7428311-applied-biosciences-corp-provides-corporate-update-and-discusses-strategy-for-focus-on-building

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/

About Applied BioSciences Corp.

Applied BioSciences is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. We also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit appliedbiocorp.com and connect with the Company on Twitter, Facebook and LinkedIn

A

Share
New Message
Please login to post a reply